Not exact matches
The much - maligned (and financially hobbled) Valeant Pharmaceuticals got a spark of good news Wednesday
as the FDA approved its Siliq (brodalumab), a treatment for moderate - to -
severe plaque
psoriasis.
Certain health concerns that can arise include depression, arthritis, anemia, fatigue and even more
severe conditions such
as dementia, colitis,
psoriasis and osteoporosis.
Treatment options for moderate to
severe psoriasis include phototherapy; systemic medications such
as acitretin, cyclosporine and methotrexate; and biologics, which block the immune system responses that fuel inflammation.
Severe psoriasis is characterized by more than 20 % body coverage or
psoriasis that develops in certain critical areas, such
as the face.
People with mild
psoriasis might be just
as likely to develop arthritis
as someone with a
severe form of the disease.
Secondly: Whether you have a diagnosis for
psoriasis or not, although the symptoms of different types of
psoriasis as well
as psoriatic arthritis can be diverse, many people have them even though in some people their psoriatic symptoms may be subtle and in others extremely
severe.
But in some
severe psoriasis cases I've worked with it has taken
as long
as 12 — 18 months for the healing to take place.
An analysis of the medical records of 143,883
psoriasis patients in the United Kingdom found that people with
severe psoriasis were twice
as likely to acquire chronic kidney disease
as those whose
psoriasis was mild or who had no
psoriasis at all.
Severe burns are painful and cause chronic skin conditions such
as eczema and
psoriasis.
Key Highlight: • Facilitated the introduction of HUMIRA (adalimumab) for the healthcare professionals
as the latest and the only fully human monoclonal antibody against TNF for the treatment of moderate to
severe psoriasis in patient failed at least on two DMARD's.